BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

Covering neonates to adolescents, BNF for Children includes key clinical and pharmaceutical information specific to those age groups. Peer review Although every effort is made to identify the most robust data available, inevitably there are areas where the evidence base is weak or contradictory. Joint Formulary Committee The Joint Formulary Committee (JFC) is responsible for the content of the BNF. All solid dose and all oral and external liquid preparations must be dispensed in a reclosable childresistant container unless: . Evidence assigned a level 1- or 2- score has an unacceptable level of bias or confounding and is not used to form recommendations.

How to use BNF Publications in print How to use the BNF This edition of the BNF continues to display the fundamental change to the structure of the content that was first shown in BNF 70. However, the legislation provides a statutory “medical defence” for patients taking drugs for medical reasons in accordance with instructions, if their driving was not impaired—it continues to be an offence to drive if actually impaired. Once the patent for a biological medicine has expired, a biosimilar medicine may be authorised by the European Medicines Agency (EMA). Practitioners are reminded, by a statement under the heading of “Medicinal Forms” that not all products containing a specific drug ingredient may be similarly licensed.How BNF Publications are constructed Overview The BNF is an independent professional publication that addresses the day-to-day prescribing information needs of healthcare professionals. Cost-effective prescribing must, however, take into account other factors (such as dose frequency and duration of treatment) that affect the total cost.

The British National Formulary for Children is the first choice for concise medicines information for children.Safety monitoring Biosimilar medicines are subject to a black triangle status (A) at the time of initial authorisation. For legal requirements relating to prescriptions of Controlled Drugs, see Controlled drugs and drug dependence p. This provides practical information on the preparation of intravenous drug infusions, including compatibility of drugs with standard intravenous infusion fluids, method of dilution or reconstitution, and administration rates. It is important to discuss treatment options carefully with the patient to ensure that the patient is content to take the medicine as prescribed.